Will This Asteroid Heading Toward Vertex Pharmaceuticals Make Impact?

Unlike NASA, Vertex Pharmaceuticals (NASDAQ: VRTX) can see an asteroid heading toward its cystic fibrosis franchise from at least a few years away. The first group of patients to try a potential new treatment from Translate Bio (NASDAQ: TBIO) recently completed a single-dose study, and the results are compelling.